Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Nat Protoc. 2013 Feb;8(2):430–437. doi: 10.1038/nprot.2012.153

Table 2.

TROUBLESHOOTING

Step Problem Possible cause Solution
4 and 5 Poor Attachment of hPSCs
to tissue culture plates
Variability between lines Add Rho kinase inhibitor Y-
27632 in the medium during
passaging and for the next
24 hours after passaging.
6 Decrease of pluripotency
following passaging
Break-up of hPSC
colonies is not optimal
If clumps are too big (>3000
cells), the middle of the
colony differentiates
disturbing the downstream
endoderm specification.
This can be easily avoided
by vigorous pipeting of the
clumps during passaging.
If clumps are too small
(<200 cells), hPSC will
differentiate becoming
unsuitable for downstream
liver differentiation. This can
be avoided by decreasing
enzymatic treatment and by
gently dissociating clumps
during passaging.
7, 8 and 9 Suboptimal differentiation Variability between lines DE differentiation is the
most important part of the
protocol. Indeed, artificial
hepatocytes are
systematically obtained as
long this step of the protocol
works efficiently. Thus
optimisation of the first part
of the protocol is essential..
For that, we recommend to
define the most efficient
concentration of FGF and
CHIR in step 1. For that,
cells should be
differentiated in
increasing/decreasing dose
of CHIR and / or bFGF and
then DE differentiation can
be monitored using
QPCR/Immuno and flow
cytometry analyses. At least
60% of the cells should
express those markers to
ensure an efficient hepatic
differentiation
11 Suboptimal differentiation BMP 4 effect BMP4 might have a
negative effect on
hepatoblast specification in
some hPSC lines. Thus,
step 7 can be replaced by
extending step 6 for 3
additional days (i.e. 3
additional days in RPMIB27
supplemented with
Activin). Importantly,
increasing or decreasing
dose of BMP4 has no effect
on hepatoblast specification
in vitro.
12 Suboptimal maturation Variability between lines Hepatoblast derived hPSCs
respond differentially to a
variety of basal cell culture
media and thus optimisation
might be necessary for
specific cell lines.
Hepatozyme can be used
instead of HBM.